Showing 1 – 21 of 21 results.
Curated
Restricted
Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 1998 (ICPSR 2826)
Released/updated on: 1999-11-10
Geographic coverage: United States
Time period: 1998-01-01--1998-12-31
The Arrestee Drug Abuse Monitoring (ADAM) Program measures levels of and trends in drug use among persons arrested and booked in the United States. The ADAM Program is a redesigned version of the Drug Use Forecasting (DUF) Program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]), upgraded methodologically and expanded to include 35 cities. The data address the following topics: (1) types of drugs used by arrestees (based on self-reports and urinalysis), (2) self-reported dependency on drugs, (3) self-reported need for alcohol/drug treatment, (4) the relationship between drug use and certain types of offenses, and (5) the relationship between self-reported indicators of drug use and indicators of drug use based on urinalysis. Participation in the project is voluntary, and all information collected from the arrestees is anonymous and confidential. The data include the arrestee's age, race, gender, educational attainment, marital status, and the charge at the time of booking. The recently modified ADAM/DUF interview instrument (used for part of the 1995 DUF data and all of the DUF 1996, DUF 1997, and ADAM 1998 data) also collected information about the arrestee's self-reported use of 15 drugs. For each drug type, arrestees were asked whether they had ever used the drug, the age at which they first used the drug, whether they had used the drug within the past three days, how many days they had used the drug within the past month, whether they had ever needed or felt dependent on the drug, and whether they were dependent on the drug at the time of the interview. Data from the new interview instrument also included information about whether arrestees had ever injected drugs and whether they were influenced by drugs when they allegedly committed the crimes for which they were arrested. The data also include information about whether the arrestee had been to an emergency room for drug-related incidents and whether he or she had prior arrests in the last 12 months. Data that continue to be collected with the new version of the ADAM/DUF interview provide information about arrestees' histories of drug/alcohol treatment, including whether they ever received drug/alcohol treatment and whether they needed drug/alcohol treatment. As part of the ADAM program, arrestees were asked to provide a urine specimen, which was screened for the presence of the following ten drug types: marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography).
Curated
Restricted
Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 1999 (ICPSR 2994)
Released/updated on: 2006-03-30
Geographic coverage: United States
Time period: 1999-01-01--1999-12-31
The Arrestee Drug Abuse Monitoring (ADAM) Program, the successor to the Drug Use Forecasting (DUF) Program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]), measures levels of and trends in drug use among persons arrested and booked in 35 sites across the United States. The data address the following topics: (1) types of drugs used by arrestees (based on self-reports and urinalysis), (2) self-reported dependency on drugs, (3) self-reported need for alcohol/drug treatment, (4) the relationship between drug use and certain types of offenses, and (5) the relationship between self-reported indicators of drug use and indicators of drug use based on urinalysis. Participation in the project is voluntary, and all information collected from the arrestees is anonymous and confidential. The data include the arrestee's age, race, gender, educational attainment, marital status, and the charge at the time of booking. The modified ADAM/DUF interview instrument (used for part of the 1995 data and all of the 1996, 1997, 1998, and 1999 data) also collected information about the arrestee's use of 15 drugs, including recent and past use (e.g., 3-day and 30-day drug use), age at first use, and whether the arrestee had ever been dependent on drugs. As part of the ADAM program, arrestees were asked to provide a urine specimen, which was screened for the presence of ten drugs, including marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography).
Curated
Restricted
Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2000 (ICPSR 3270)
Released/updated on: 2006-03-30
Geographic coverage: United States
Time period: 2000-01-01--2000-12-31
Beginning in 1996, the National Institute of Justice (NIJ) initiated a major redesign of its multisite drug-monitoring program, the Drug Use Forecasting (DUF) system (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]). The program was retitled Arrestee Drug Abuse Monitoring (ADAM) (see ARRESTEE DRUG ABUSE MONITORING (ADAM) PROGRAM IN THE UNITED STATES, 1998 [ICPSR 2628] and 1999 [ICPSR 2994]). ADAM extended DUF in the number of sites and improved the quality and generalizability of the data. The redesign was fully implemented in all sites beginning in the first quarter of 2000. The ADAM program implemented a new and expanded adult instrument in the first quarter of 2000, which was used for both the male (Part 1) and female (Part 2) data. The juvenile data for 2000 (Part 3) used the juvenile instrument from previous years. The ADAM program also moved to probability-based sampling for the adult male population during 2000. Therefore, the 2000 adult male sample includes weights, generated through post-sampling stratification of the data. The shift to sampling of the adult male population in 2000 required that all 35 sites move to a common catchment area, the county. The core instrument for the adult cases was supplemented by a facesheet, which was used to collect demographic and charge information from official records. Core instruments were used to collect self-report information from the respondent. Both the adult and juvenile instruments were administered to persons arrested and booked on local or state charges relevant to the jurisdiction (i.e., not federal or out-of-county charges) within the past 48 hours. At the completion of the interview the arrestee was asked to voluntarily provide a urine specimen. An external lab used the Enzyme Multiplied Immunoassay Testing (EMIT) protocols to test for the presence of ten drugs or metabolites of the drug in the urine sample. All amphetamine positives were confirmed by gas chromatography/mass spectrometry (GC/MS) to determine whether methamphetamine was used. For the adult data, variables from the facesheet include arrest precinct, ZIP code of arrest location, ZIP code of respondent's address, respondent's gender and race, three most serious arrest charges, sample source (stock, flow, other), interview status (including reason the individual selected in the sample was not interviewed), language of instrument used, and the number of hours since arrest. Demographic information from the core instrument includes respondent's age, ethnicity, residency, education, employment, health insurance coverage, marital status, housing, and telephone access. Variables from the calendar provide information on inpatient and outpatient substance abuse treatment, inpatient mental health treatment, arrests and incarcerations, heavy alcohol use, use of marijuana, crack/rock cocaine, powder cocaine, heroin, methamphetamine, and other drug (ever and previous 12 months), age of first use of the above six drugs and heavy alcohol use, drug dependency in the previous 12 months, characteristics of drug transactions in past 30 days, use of marijuana, crack/rock cocaine, powder cocaine, heroin, and methamphetamine in past 30 days, 7 days, and 48 hours, heavy alcohol use in past 30 days, and secondary drug use of 15 other drugs in the past 48 hours. Urine test results are provided for 11 drugs -- marijuana, cocaine, opiates, phencyclidine (PCP), benzodiazepines (Valium), propoxyphene (Darvon), methadone, methaqualone, barbiturates, amphetamines, and methamphetamine. The adult data files include several derived variables. The male data also include four sampling weights, and stratum identifications and percents. For the juvenile data, demographic variables include age, race, sex, educational attainment, employment status, and living circumstances. Data also include each juvenile arrestee's self-reported use of 15 drugs (alcohol, tobacco, marijuana, powder cocaine, crack, heroin, PCP, amphetamines, barbiturates, quaaludes, methadone, crystal methamphetamine, Valium, LSD, and inhalants). For each drug type, arrestees reported whether they had ever used the drug, age of first use, whether they had used the drug in the past 30 days and past 72 hours, number of days they used the drug in past month, whether they tried to cut down or quit using the drug, if they were successful, whether they felt dependent on the drug, whether they were receiving treatment for the drug, whether they had received treatment for the drug in the past, and whether they thought they could use treatment for that drug. Additional variables include whether juvenile respondents had ever injected drugs, whether they were influenced by drugs when they allegedly committed the crime for which they were arrested, whether they had been to an emergency room for drug-related incidents, and if so, whether in the past 12 months, and information on arrests and charges in the past 12 months. As with the adult data, urine test results are also provided. Finally, variables covering precinct (precinct of arrest) and law (penal law code associated with the crime for which the juvenile was arrested) are also provided for use by local law enforcement officials at each site.
Curated
Restricted
Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2001 (ICPSR 3688)
Released/updated on: 2006-03-30
Geographic coverage: North Carolina, Oklahoma City, Detroit, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Sacramento, Seattle, California, Pennsylvania, Tulsa, Laredo, Iowa, Illinois, Texas, Portland (Oregon), Indianapolis, Oregon, United States, Oklahoma, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Colorado, Honolulu, Missouri, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, San Antonio, Chicago, Hawaii, Minnesota, Kansas City (Missouri), New York (state), Birmingham, Michigan, New Mexico, Louisiana, Anchorage, Ohio, Philadelphia
Time period: 2001-01-01--2001-12-31
The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2001 at four separate times (quarterly) during the year in 33 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. Data from arrestees in juvenile detention facilities (Part 3) continued to use the juvenile instrument from previous years, extending back through the DRUG USE FORECASTING series (ICPSR 9477). The ADAM program in 2001 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) weights. The juvenile file contains demographic variables and arrestee's self-reported past and continued use of 15 drugs, as well as other drug-related behaviors.
Curated
Restricted
Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2002 (ICPSR 3815)
Released/updated on: 2006-03-30
Geographic coverage: North Carolina, Oklahoma City, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Sacramento, Seattle, California, Washington, District of Columbia, Pennsylvania, Tulsa, Laredo, Iowa, Illinois, Texas, Portland (Oregon), Georgia, Indianapolis, Oregon, United States, Oklahoma, Rio Arriba, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Woodbury, Atlanta, Colorado, Honolulu, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, San Antonio, Chicago, Hawaii, Minnesota, New York (state), Birmingham, New Mexico, Louisiana, Anchorage, Ohio, Los Angeles, Philadelphia
Time period: 2002-01-01--2002-12-31
The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2002 at four separate times (quarterly) during the year in 36 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. Data from arrestees in juvenile detention facilities (Part 3) continued to use the juvenile instrument from previous years, extending back through the DRUG USE FORECASTING series (ICPSR 9477). The ADAM program in 2002 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence, (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) weights. The juvenile file contains demographic variables and arrestee's self-reported past and continued use of 15 drugs, as well as other drug-related behaviors.
Curated
Restricted
Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2003 (ICPSR 4020)
Released/updated on: 2006-03-30
Geographic coverage: North Carolina, Oklahoma City, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Boston, Sacramento, Seattle, California, Florida, Pennsylvania, Tulsa, Iowa, Illinois, Texas, Portland (Oregon), Georgia, Tampa, Indianapolis, Oregon, United States, Oklahoma, Rio Arriba, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Woodbury, Atlanta, Massachusetts, Colorado, Honolulu, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, District of Columbia, San Antonio, Chicago, Hawaii, Minnesota, New York (state), Birmingham, Miami, New Mexico, Louisiana, Anchorage, Ohio, Los Angeles, Philadelphia, Houston
Time period: 2003-01-01--2003-12-31
The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2003 up to four separate times (quarterly) during the year in 39 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. The ADAM program in 2003 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult male and female files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence, (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) for males, weights.
Curated
Restricted
Arrestee Drug Abuse Monitoring (ADAM) Project in Rural Nebraska, 1998 (ICPSR 28141)
Released/updated on: 2011-01-28
Geographic coverage: Omaha, United States, Nebraska
Time period: 1998-10-01--1998-11-01
A pilot outreach project of the National Intstitute of Justice's Arrestee Drug Abuse Monitoring (ADAM) program, the rural Nebraska ADAM program examined the prevalence and type of arrestee drug use in four rural Nebraska counties and compared the results to those found in Omaha, Nebraska, an established ADAM site. The data were collected in Madison (n=78), Dawson (n=50), Hall (n=53), and Scotts Bluff (n=149) counties, and Omaha, Nebraska, (n=202) in October and November of 1998. The catchment area for Omaha was the central city. The ADAM interview provided demographic and descriptive data, including race, age, marital status, source of income, screens of substance abuse and dependency, treatment history, arrest and incarceration experiences, and participation in local drug markets. At the conclusion of the interview, respondents were asked to provide a urine specimen. The current study included a supplemental questionnaire about methamphetamine use. The methamphetamine addendum included variables on why the respondent began and continued the use of methamphetamines, how often and how much methamphetamine was used, if and why the respondent had ever sought and completed treatment, source of the methamphetamine, and if the respondent had ever made or sold methamphetamine.
Curated
Restricted
Arrestee Drug Abuse Monitoring II in the United States, 2013 (Restricted Use) (ICPSR 35169)
Released/updated on: 2014-08-01
Geographic coverage: New York City, Sacramento, United States, Chicago, Atlanta, Illinois, Colorado, Denver, California, Georgia, New York (state)
Time period: 2013-05-05--2013-07-28
The Arrestee Drug Abuse Monitoring II, 2013 is a collection of interview and bioassay data provided by over 3000 arrestees from five county sites within the United States. Under the sponsorship of the Office of National Drug Control Policy (ONDCP), the ADAM II program monitors drug use and related behaviors (treatment experiences, housing stability, drug market activity, age at first use, employment, etc.) in a probability based sample of male adult arrestees within 48 hours of their arrest. The five ADAM II sites for 2013 were: Atlanta, GA (Fulton County and the City of Atlanta); Chicago, IL (Cook County); Denver, CO (Denver County); New York, NY (Borough of Manhattan); and Sacramento, CA (Sacramento County). The 2013 survey represents the seventh year of ADAM II and includes data from 1,900 interviews and 1,681 urine tests that were conducted at the five ADAM II sites over a 21-day period, between May 5, 2013 and July 28, 2013. ADAM II data include official records, arrestee responses from a 20-minute face-to-face interview, and results from voluntary urine samples which tested for the presence of nine different drugs. Identifying information on the arrestees was not retained or shared with law enforcement. Demographic variables include age, gender, race, citizenship, marital status, arrest date and time, county of arrest, number and type(s) of offense(s), education, work status, and language of interview.
Curated
Restricted
Arrestee Drug Abuse Monitoring Program II in the United States, 2009 (ICPSR 30061)
Released/updated on: 2011-02-24
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 7,794 arrestees were interviewed during the second and third quarters of 2009. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2009, and ending September 30, 2009. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated
Restricted
Arrestee Drug Abuse Monitoring Program II in the United States, 2010 (ICPSR 32321)
Released/updated on: 2011-11-04
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 8,332 arrestees were interviewed during the second and third quarters of 2010. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2010, and ending September 30, 2010. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated
Restricted
Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six Cities in the United States, 1995-1996 (ICPSR 2564)
Released/updated on: 2012-08-22
Geographic coverage: New York City, Oregon, District of Columbia, San Diego, San Antonio, United States, Chicago, Illinois, Texas, Portland (Oregon), California, New York (state)
Time period: 1995-01-01--1996-01-01
This study was designed to address the practical and policy implications of various drug market participation patterns. In 1995, the Office of National Drug Control Policy (ONDCP) and the National Institute of Justice (NIJ) collaborated on a project called the Procurement Study. This study was executed as an addendum to NIJ's Drug Use Forecasting (DUF) program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]) with the goal of extending previous research in which heroin users were interviewed on various aspects of drug market activity. The present study sought to explore additional features of drug market participation and use, both within and across drug types and cities, and included two additional drugs -- powder cocaine and crack cocaine. Data were collected from recently arrested users of powder cocaine, crack cocaine, and heroin in six DUF cities (Chicago, New York, Portland, San Diego, San Antonio, and Washington, DC). Each of the three files in this collection, Crack Data (Part 1), Heroin Data (Part 2), and Powder Cocaine Data (Part 3), is comprised of data from a procurement interview, urine test variables, and a DUF interview. During the procurement interview, information was collected on purchase and use patterns for specific drugs. Variables from the procurement interview include the respondent's method of using the drug, the term used to refer to the drug, whether the respondent bought the drug in the neighborhood, the number of different dealers the respondent bought the drug from, how the respondent made the connection with the dealer (i.e., street, house, phone, beeper, business/store, or friends), their main drug source, whether the respondent went to someone else if the source was not available, how the respondent coped with not being able to find drugs to buy, whether the respondent got the drug for free, the means by which the respondent obtained money, the quantity and packaging of the drug, and the number of minutes spent searching for, traveling to, and waiting for their last purchase. Urine tests screened for the presence of ten drugs, including marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography). Data from the DUF interview provide detailed information about each arrestee's self-reported use of 15 drugs. For each drug type, arrestees were asked whether they had ever used the drug, the age at which they first used the drug, whether they had used the drug within the past three days, how many days they had used the drug within the past month, whether they had ever needed or felt dependent on the drug, and whether they were dependent on the drug at the time of the interview. Data from the DUF interview instrument also included alcohol/drug treatment history, information about whether arrestees had ever injected drugs, and whether they were influenced by drugs when the crime that they were charged with was committed. The data also include information about whether the arrestee had been to an emergency room for drug-related incidents and whether he or she had had prior arrests in the past 12 months. Demographic data include the age, race, sex, educational attainment, marital status, employment status, and living circumstances of each respondent.
Curated
Crime Days Precursors Study: Baltimore, 1952-1976 (ICPSR 8222)
Released/updated on: 1992-02-16
Geographic coverage: Baltimore, United States, Maryland
Time period: 1952-01-01--1976-01-01
This data collection focuses on 354 male narcotic addicts who were selected using a stratified random sample from a population of 6,149 known narcotic abusers arrested or identified by the Baltimore, Maryland, Police Department between 1952 and 1976. Variables include respondent's use of controlled drugs, including marijuana, hallucinogens, amphetamines, barbiturates, codeine, heroin, methadone, cocaine, tranquilizers, and other narcotics. Also of interest is the respondent's past criminal activity including arrests, length of incarceration, educational attainment, employment history, personal income, mobility, and drug treatment, if any.
Curated
Restricted
Domestic Violence and Substance Abuse Among the Arrestee Population in Albuquerque, New Mexico, 1999-2001 (ICPSR 3585)
Released/updated on: 2003-06-25
Geographic coverage: United States, New Mexico
Time period: 1999-01-01--2001-01-01
The focus of this study was to examine levels of aggressive behavior during incidents of domestic violence in relation to self-reported drug and alcohol use among an arrestee population from Bernalillo County in Albuquerque, New Mexico. The research questions motivating this project were: (1) Are acts of domestic violence committed while the offender is taking illicit psychoactive substances, as ascertained by self-reports? (2) For those individuals with domestic violence charges, do urinalyses conducted within 48 hours of an individual's arrest indicate the recent use of a psychoactive substance? (3) Which substances are most prevalently associated with incidents of domestic violence? (4) Is there a difference in levels of aggressive behavior that is dependent on the individual? (5) Does the severity of domestic violence increase with the presence of psychoactive substances? (6) What differences (if any) exists between batterers who take psychoactive substances and batterers who do not? The data for this research were collected in conjunction with the National Institute of Justice's Arrestee Drug Abuse Monitoring (ADAM) programs. The domestic violence survey addendum was administered to all arrestees from Bernalillo County in Albuquerque, New Mexico, who had completed the ADAM interview and provided a urine specimen and were willing to answer additional questions concerning domestic violence. Variables from the ADAM instruments were comprised of demographic data on each arrestee, calendar of admissions to drug treatment-related programs, data on dependence and abuse, drug market and use data, and urine test results. Variables from the domestic violence addendum include demographics on the intimate partner, whether specific physical events occurred, whether specific injuries had been sustained by both arrestee and partner, and the specific circumstances surrounding the physical abuse event.
Curated
Impact of Forensic Evidence on the Criminal Justice Process in Five Sites in the United States, 2003-2006 (ICPSR 29203)
Released/updated on: 2010-10-27
Geographic coverage: Indiana, United States, Los Angeles, California, Fort Wayne, South Bend, Evansville, Indianapolis
Time period: 2003-01-01--2006-01-01
The purpose of the study was to investigate the role and impact of forensic science evidence on the criminal justice process. The study utilized a prospective analysis of official record data that followed criminal cases in five jurisdictions (Los Angeles County, California; Indianapolis, Indiana; Evansville, Indiana; Fort Wayne, Indiana; and South Bend, Indiana) from the time of police incident report to final criminal disposition. The data were based on a random sample of the population of reported crime incidents between 2003 and 2006, stratified by crime type and jurisdiction. A total of 4,205 cases were sampled including 859 aggravated assaults, 1,263 burglaries, 400 homicides, 602 rapes, and 1,081 robberies. Descriptive and impact data were collected from three sources: police incident and investigation reports, crime lab reports, and prosecutor case files. The data contain a total of 175 variables including site, crime type, forensic variables, criminal offense variables, and crime dispositions variables.
Curated
Monitoring Drug Epidemics and the Markets That Sustain Them, Arrestee Drug Abuse Monitoring (ADAM) and ADAM II Data, 2000-2003 and 2007-2010 (ICPSR 33201)
Released/updated on: 2012-12-13
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
Time period: 2000-01-01--2003-01-01, 2007-01-01--2010-01-01
This study examined trends in the use of five widely abused drugs among arrestees at 10 geographically diverse locations from 2000 to 2010: Atlanta, Charlotte, Chicago, Denver, Indianapolis, Manhattan, Minneapolis, Portland Oregon, Sacramento, and Washington DC. The data came from the Arrestee Drug Abuse Monitoring Program reintroduced in 2007 (ADAM II) and its predecessor the ADAM program. ADAM data included urinalysis results that provided an objective measure of recent drug use, provided location specific estimates over time, and provided sample weights that yielded unbiased estimates for each location. The ADAM data were analyzed according to a drug epidemics framework, which has been previously employed to understand the decline of the crack epidemic, the growth of marijuana use in the 1990s, and the persistence of heroin use. Similar to other diffusion of innovation processes, drug epidemics tend to follow a natural course passing through four distinct phases: incubation, expansion, plateau, and decline. The study also searched for changes in drug markets over the course of a drug epidemic.
Curated
Restricted
Monitoring Drug Markets in Manhattan [New York City], With the Arrestee Drug Abuse Monitoring (ADAM) Program, 1998-2002 (ICPSR 22381)
Released/updated on: 2009-06-03
Geographic coverage: New York City, United States, New York (state)
Time period: 1998-01-01--2002-01-01
The purpose of the study was to determine how much Manhattan (New York City) arrestees surveyed by the Arrestee Drug Abuse Monitoring (ADAM) program spend on drug expenses. The program obtained both self-report and urinalysis data from a total of 5,210 Manhattan arrestees surveyed by the ADAM program from 1998 to 2002. The principal investigators developed a formula for an episodic estimator of a respondent's drug expense for cash, noncash, and cash-combination transactions. The dataset contains a total of 267 variables relating to Manhattan arrestees' demographics, interview information, criminal history, urinalysis test results, drug use, drug market transactions, and drug expenses.
Curated
Restricted
Pathological Gambling in Arrestee Populations in Des Moines, Iowa, and Las Vegas, Nevada, 2000-2001 (ICPSR 3499)
Released/updated on: 2003-06-05
Geographic coverage: Des Moines, Iowa, United States, Las Vegas, Nevada
Time period: 2000-01-01--2001-01-01
This study sought to examine the extent, nature, and consequences of pathological gambling disorders in arrestee populations. Five research questions were addressed: (1) What is the prevalence of pathological gambling in arrestee populations? (2) What is the profile of the pathological gambler arrested for felony and misdemeanor offenses? (3) How does the nature and level of criminal activity among pathological gamblers compare to that of non- pathological gamblers? (4) What proportion of the crime committed by offenders with pathological gambling disorders is linked to their gambling activities (either to fund gambling or pay off gambling debts)? and (5) How does substance abuse interact with pathological gambling to affect the nature and extent of criminal activity? The data for this research were collected in conjunction with the National Institute of Justice's Arrestee Drug Abuse Monitoring (ADAM) programs. Arrestees in Las Vegas, Nevada, and Des Moines, Iowa, who had completed the ADAM interview and provided a urine specimen were asked if they would be willing to answer an additional set of questions concerning their gambling behavior. Data from the ADAM interview and drug screening were merged with data collected using the gambling addendum, producing the dataset for this study. Variables from the ADAM instruments were comprised of demographic data on each arrestee, calendar of admissions to drug treatment-related programs, data on dependence and abuse, drug market and use data, and urine test results. The gambling addendum was used to collect data on five topics: (1) past-year gambling activity, (2) the use of alcohol and illegal drugs prior to and during gambling, (3) substance abuse and/or self-reported gambling problems, (4) past-year criminal activity (property, drug, and violent offending), and (5) motivations for criminal activity (gambling or non-gambling related).
Curated
Simple Crosstabs
Recidivism in the National Longitudinal Survey of Youth 1997 - Standalone Data (Rounds 1 to 13) (ICPSR 34562)
Released/updated on: 2014-02-06
Geographic coverage: United States
Time period: 1997-01-01--2009-01-01
The NLSY97 standalone data files are intended to be used by crime researchers for analyses without requiring supplementation from the main NLSY97 data set. The data contain age-based calendar year variables on arrests and incarcerations, self-reported criminal activity, substance use, demographic variables and relevant variables from other domains which are created using the NLSY97 data. The main NLSY97 data are available for public use and can be accessed online at the NLS Investigator Web site and at the NACJD Web site (as ICPSR 3959). Questionnaires, user guides and other documentation are available at the same links. The National Longitudinal Survey of Youth 1997 (NLSY97) was designed by the United States Department of Labor, comprising the National Longitudinal Survey (NLS) Series. Created to be representative of United States residents in 1997 who were born between the years of 1980 and 1984, the NLSY97 documents the transition from school to work experienced by today's youths through data collection from 1997. The majority of the oldest cohort members (age 16 as of December 31, 1996) were still in school during the first survey round and the youngest respondents (age 12) had not yet entered the labor market.
Curated
Restricted
Substance Use Among Violently Injured Youth in an Urban Emergency Department: Services and Outcomes in Flint, Michigan, 2009-2013 (ICPSR 36558)
Released/updated on: 2016-09-23
Geographic coverage: Flint, United States, Michigan
Time period: 2009-12-01--2013-09-01
This project was an investigation into the natural course of service needs, use, and trajectories among high-risk youth and young adults with drug use who presented to an inner-city Emergency Department with multiple risk behaviors (with and without acute violent injury). Eligible participants included youth/young adults (ages 14-24) who sought care at the Hurley Medical Center (HMC) Emergency Department (ED) located in Flint, Michigan between December 19, 2009 and September 7, 2011. Consenting youth completed a self-administered computerized screening survey. All participants who self-reported past year drug use were recruited for the longitudinal study. For a comparison group, a randomly selected sample of drug using youth seeking ED care for other reasons (e.g. abdominal pain, motor vehicle crash) were selected for longitudinal study (equilibrated monthly proportionally for age/gender with the acute violent injury group). Participants in the violent injury and comparison group completed a baseline assessment during their ED visit.
Dataset 1 (DS1) contains the Baseline Screener Data of both young adults and youth. This data file has 1,448 cases and 314 variables. Each case represents an individual seeking treatment in the emergency department.
Dataset 2 (DS2) contains the Baseline Youth Data. This data file has 89 cases and 531 variables. Of these 89 cases, 51 of the youths (ages 14-17) presented to the Emergency Department with a violent injury. The remaining 38 respondents reported to the Emergency Department for non-violent injury and are part of the comparison group.
Dataset 3 (DS3) contains the Baseline Young Adult Data. This file contains 511 cases and 483 variables. Of these 511 cases, 299 of the young adults (ages 18-24) presented to the Emergency Department with a violent injury. The remaining 212 respondents reported to the Emergency Department for non-violent injury and are part of the comparison group.
The Baseline Screener Data includes demographics and information about public assistance, income, work, marital status, insurance, the injury visit, school/grades, retaliation attitudes, fights, violence, gang affiliation, weapons, partner violence, nicotine use, alcohol use, drug use, HIV risk-taking behaviors, needle use, sexual behavior, STD/HIV, past adolescent injuries, age on onset of drug use, and current conflict and aggression.
The Baseline Youth and Young Adult Data include sexual behavior, threat of retaliation, brief symptom inventory/suicide risk, drug and alcohol refusal efficacy, drinking and driving (DUI), community involvement, peer influences, non-partner aggression, parental support, parent influence on drug and alcohol use, family conflict, mentors, fight self-efficacy, community violence, sexual risk behaviors, medical care, alcohol dependence/abuse, drug dependence/abuse, substance abuse service utilization, post traumatic stress disorder (PTSD), conduct disorder (youth) or antisocial personality disorder (young adult), legal system involvement, major depressive episodes, and mental health service utilization.
Curated
Simple Crosstabs
Substance Use Among Violently Injured Youth in an Urban Emergency Department: Services and Outcomes in Flint, Michigan, 2009-2013 (Public-Use) (ICPSR 36769)
Released/updated on: 2017-03-31
Geographic coverage: Flint, United States, Michigan
Time period: 2009-12-01--2013-09-01
This project was an investigation into the natural course of service needs, use, and trajectories among high-risk youth and young adults with drug use who presented to an inner-city Emergency Department with multiple risk behaviors (with and without acute violent injury). Eligible participants included youth/young adults (ages 14-24) who sought care at the Hurley Medical Center (HMC) Emergency Department (ED) located in Flint, Michigan between December 19, 2009 and September 7, 2011. Consenting youth completed a self-administered computerized screening survey. All participants who self-reported past year drug use were recruited for the longitudinal study. For a comparison group, a randomly selected sample of drug using youth seeking ED care for other reasons (e.g. abdominal pain, motor vehicle crash) were selected for longitudinal study (equilibrated monthly proportionally for age/gender with the acute violent injury group). Participants in the violent injury and comparison group completed a baseline assessment during their ED visit.
Dataset 1 (DS1) contains the Baseline Screener Data of both young adults and youth. This data file has 1,448 cases and 253 variables. Each case represents an individual seeking treatment in the emergency department.
Dataset 2 (DS2) contains the Baseline Youth Data. This data file has 89 cases and 363 variables. Of these 89 cases, 51 of the youths (ages 14-17) presented to the Emergency Department with a violent injury. The remaining 38 respondents reported to the Emergency Department for non-violent injury and are part of the comparison group.
Dataset 3 (DS3) contains the Baseline Young Adult Data. This file contains 511 cases and 380 variables. Of these 511 cases, 299 of the young adults (ages 18-24) presented to the Emergency Department with a violent injury. The remaining 212 respondents reported to the Emergency Department for non-violent injury and are part of the comparison group.
The Baseline Screener Data includes demographics and information about public assistance, income, work, marital status, insurance, the injury visit, school/grades, retaliation attitudes, fights, violence, gang affiliation, weapons, partner violence, nicotine use, alcohol use, drug use, HIV risk-taking behaviors, needle use, sexual behavior, STD/HIV, past adolescent injuries, age on onset of drug use, and current conflict and aggression.
The Baseline Youth and Young Adult Data include brief sexual behavior, threat of retaliation, brief symptom inventory, drug and alcohol refusal efficacy, drinking and driving (DUI), community involvement, peer influences, non-partner aggression, parental support, parent influence on drug and alcohol use, family conflict, mentors, fight self-efficacy, community violence, medical care, alcohol dependence/abuse, drug dependence/abuse, substance abuse service utilization, post traumatic stress disorder (PTSD), conduct disorder (youth) or antisocial personality disorder (young adult), legal system involvement, major depressive episodes, and mental health service utilization.
Curated
Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1991: Homeless and Transient Population (ICPSR 2346)
Released/updated on: 2008-07-24
Geographic coverage: United States
The DC Metropolitan Area Drug Study (DC*MADS) was conducted in 1991, and included special analyses of homeless and transient populations and of women delivering live births in the DC hospitals. DC*MADS was undertaken to assess the full extent of the drug problem in one metropolitan area. The study was comprised of 16 separate studies that focused on different sub-groups, many of which are typically not included or are underrepresented in household surveys.
The Homeless and Transient Population study examines the prevalence of illicit drug, alcohol, and tobacco use among members of the homeless and transient population aged 12 and older in the Washington, DC, Metropolitan Statistical Area (DC MSA). The sample frame included respondents from shelters, soup kitchens and food banks, major cluster encampments, and literally homeless people. Data from the questionnaires include history of homelessness, living arrangements and population movement, tobacco, drug, and alcohol use, consequences of use, treatment history, illegal behavior and arrest, emergency room treatment and hospital stays, physical and mental health, pregnancy, insurance, employment and finances, and demographics. Drug specific data include age at first use, route of administration, needle use, withdrawal symptoms, polysubstance use, and perceived risk.